Skip to main content
. 2019 Feb 27;19:199. doi: 10.1186/s12879-019-3823-8

Table 1.

Multidrug resistance, resistance to chlorhexidine and resistance to methicillin from 211 clinical isolates of CoNS by species

Species n (%) MDR n (%) MIC of CHX ≥ 4 mg/L n (%) MIC of CHX ≥ 4 mg/L and MR n (%)
S. epidermidis 65 (31) 54 (83) 25 (38.4) 22 (33,8)
S. hominis hominis 32 (15.1) 26 (81) 10 (31.2) 10 (31,2)
S. auricularis 25 (12) 24 (96) 13 (52) 11 (44)
S. haemolyticus 24 (11.3) 21 (87.5) 8 (33.3) 8 (33,3)
S. capitis urealyticus 11 (5.2) 10 (91) 4 (36.3) 4 (36,3)
S. saccharolyticus 5 (2.3) 4 (80) 1 (20) 1 (20)
S. chonii urealyticum 5 (2.3) 5 (100) 0 0
S. cohnii cohnii 4 (1.8) 4 (100) 0 0
S. saprophyticus 4 (1.8) 4 (100) 1 (25) 1 (25)
S. capitis capitis 3 (1.4) 3 (100) 1 (33.3) 1 (33,3)
S. chromogenes 2 (1.4) 2 (100) 0 0
S. xylosus 1 (0.4) 1 (100) 0 0
S. simulans 1 (0.4) 1 (100) 0 0
S. sciuri 1 (0.4) 1 (100) 0 0
Unidentified CoNS 28 (13.2) 24 (85.7) 2 (7.1) 2 (7,1)
Total 211 (100) 184 (87) 65 (31) 60 (28,4)

MRD multidrug resistance, MIC minimum inhibitory concentration, CHX chlorhexidine, CoNS Coagulase-negative staphylococci, MR Methicillin-resistant